Consensus Guidelines for the Use of Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors in the Management of Hormone Receptor Positive (HR+ve), Her2-ve Early Breast Cancer (EBC)
细胞周期蛋白依赖性激酶 (CDK) 4/6 抑制剂在激素受体阳性 (HR+ve)、Her2 阴性早期乳腺癌 (EBC) 治疗中的应用共识指南
期刊:South Asian Journal of Cancer
影响因子:0.8
doi:10.1055/s-0044-1791768
Parikh, Purvish M; Vora, Amish; Yadav, Rajan; Kapoor, Akhil; Sahoo, Tarini; Rajappa, Senthil; Kanakashetty, Govind Babu; Krishna, M Vamshi; Biswas, Ghanashyam; Bahl, Ankur; Ghadyalpatil, Nikhil; Raja, Thirumalairaj; Bajpai, Jyoti; Akhade, Amol; Singh, Randeep; Aggarwal, Shyam; Basade, Maheboob; Advani, S H